Mr Main...If Pfizer is the only bidder, Amarin accepts $15/sh...
If another bidder appears, Amarin goes for $20/sh or up.
This is a low point...Amarin has the prospects and the finances to wait for a better day...There will also be other bidders, interested in the next CVD success to rival the statin drugs
This is a marathon, not a sprint...Vascepa will be around long after the patents have run out...I've been waiting for ten years...My kids can wait another ten tears if necessary.
Market Data 
Markets 
AI
